KALA BIO, Inc (KALA)
NGS · Common · CUSIP 483119202
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for KALA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
483119202 (prev. 483119103 )
Market Cap
Micro Cap
IPO
7/19/2017 · $15.00/share
Previous Name
Kala Pharmaceuticals, Inc.
Business: KALA BIO, Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases.

Company Contact

CEO
Todd Dazemore
CFO
Mary Reumuth
Headquarters
1167 Massachusetts Avenue, Arlington, MA 02476
Phone
781-996-5252
Fax
781-642-0399
Investor Relations
Taylor Steiner, Precision AQ · 212-362-1200 · taylor.steiner@precisionaq.com
SEC EDGAR Filings
View filings »